CA2993329C - Compose ciblant le facteur d'activation d'il-23 et des lymphocytes b (baff) et utilisations associees - Google Patents

Compose ciblant le facteur d'activation d'il-23 et des lymphocytes b (baff) et utilisations associees

Info

Publication number
CA2993329C
CA2993329C CA2993329A CA2993329A CA2993329C CA 2993329 C CA2993329 C CA 2993329C CA 2993329 A CA2993329 A CA 2993329A CA 2993329 A CA2993329 A CA 2993329A CA 2993329 C CA2993329 C CA 2993329C
Authority
CA
Canada
Prior art keywords
seq
amino acid
acid sequence
compound
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2993329A
Other languages
English (en)
Other versions
CA2993329A1 (fr
Inventor
Sanjaya Singh
Qi Pan
Rachel Rebecca BARRETT
Leslie S. Johnson
Pankaj Gupta
Sarah Low
Haixia Wu
Original Assignee
Boehringer Ingelheim International GmbH
Macrogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Macrogenics Inc filed Critical Boehringer Ingelheim International GmbH
Priority claimed from PCT/US2016/043267 external-priority patent/WO2017015433A2/fr
Publication of CA2993329A1 publication Critical patent/CA2993329A1/fr
Application granted granted Critical
Publication of CA2993329C publication Critical patent/CA2993329C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des composés spécifiques d'IL-23A et de BAFF, des compositions comprenant les composés, et des méthodes d'utilisation associées. L'invention concerne aussi des acides nucléiques, des cellules, et des méthodes de production associées aux composés et compositions.
CA2993329A 2015-07-23 2016-07-21 Compose ciblant le facteur d'activation d'il-23 et des lymphocytes b (baff) et utilisations associees Active CA2993329C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562196170P 2015-07-23 2015-07-23
US62/196,170 2015-07-23
US201562201067P 2015-08-04 2015-08-04
US62/201,067 2015-08-04
US201662355302P 2016-06-27 2016-06-27
US62/355,302 2016-06-27
PCT/US2016/043267 WO2017015433A2 (fr) 2015-07-23 2016-07-21 Composé ciblant le facteur d'activation d'il-23 et des lymphocytes b (baff) et utilisations associées

Publications (2)

Publication Number Publication Date
CA2993329A1 CA2993329A1 (fr) 2017-01-26
CA2993329C true CA2993329C (fr) 2026-02-17

Family

ID=

Similar Documents

Publication Publication Date Title
US11884744B2 (en) Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
US20230382988A1 (en) Compound targeting il-23a and tnf-alpha and uses thereof
EA040031B1 (ru) Соединение, нацеленное на ил-23a и фактор активации в-лимфоцитов (baff), и его применение
BR122021007560B1 (pt) Composto polipeptídico direcionado à il-23a, seu uso e composição farmacêutica
BR112018001255B1 (pt) Composto polipeptídico direcionado à il-23a, seu uso e composição farmacêutica
BR112017004169B1 (pt) Composto específico para a il23a e tnf-alfa compreendendo um primeiro polipeptídeo e um segundo polipeptídeo, e uso do mesmo
HK1240624B (en) Compound targeting il-23a and tnf-alpha and uses thereof
EA047781B1 (ru) Соединение, нацеленое на ил-23a и фно-альфа, и его применение